The US Food and Drug Administration (FDA) has approved Mylan Specialty's abbreviated new drug application for the generic equivalent to Sunovion's Xopenex inhalation solution, Levalbuterol inhalation solution USP, 0.31mg/3mL (0.0103%), ...
Watson Pharmaceuticals has introduced authorized generic version of Xopenex (levalbuterol HCl) inhalation solution and begun the shipment of the product. Xopenex inhalation solution indicated for the treatment or prevention of ...
Tags: Xopenex inhalation solution, bronchospasm, Sunovion Pharmaceuticals